Disease Info Card

Blood Platelet Disorders

Information about Blood Platelet Disorders: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Blood Platelet Disorders

Most recent studies have shown that Blood Platelet Disorders shares some biological mechanisms with anemia, bernard-soulier-syndrome, bleeding-tendency, blood-coagulation-disorders, disseminated-intravascular-coagulation, hematological-disease, hemophilia-a, hemorrhage, hemorrhagic-disorders, leukemia, myeloid-leukemia, platelet-storage-pool-deficiency, purpura, thrombasthenia, thrombocytopenic-purpura, thrombocytosis, thrombosis, tissue-adhesions, uremia, von-willebrand-disease.

Among the many pathways, these few ones have gauged particular interests from scientists studying Blood Platelet Disorders, and have been seen in publications frequently: Blood Coagulation, Coagulation, Excretion, Exocytosis, Fibrinolysis, Hemostasis, Localization, Megakaryocyte Development, Megakaryocyte Differentiation, Menarche, Pathogenesis, Phagocytosis, Platelet Activation, Platelet Aggregation, Platelet Formation, Protein Phosphorylation, Proteolysis, Secretion, Transport, Wound Healing

Quite a number of genes have been found to play important roles in Blood Platelet Disorders, such as ABCB6, ATP6V0A2, ATP8A2, F2, F8, GPHA2, ITGA2B, ITGB3, MYH9, PF4, PPBP, RNF130, RUNX1, SELP, SGCA, THPO, TNC, VWF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.